Publication: Comparison of efficacy of 1% silver sulfadiazine and acticoat™ for treatment of partial-thickness burn wounds
Issued Date
2006-07-27
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-33746216257
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.89, No.7 (2006), 953-958
Suggested Citation
Pornprom Muangman, Chomchark Chuntrasakul, Soranit Silthram, Supaporn Suvanchote, Rachanee Benjathanung, Suchada Kittidacha, Somphon Rueksomtawin Comparison of efficacy of 1% silver sulfadiazine and acticoat™ for treatment of partial-thickness burn wounds. Journal of the Medical Association of Thailand. Vol.89, No.7 (2006), 953-958. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/23682
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Comparison of efficacy of 1% silver sulfadiazine and acticoat™ for treatment of partial-thickness burn wounds
Other Contributor(s)
Abstract
Background: Acticoat□(Smith & Nephew, Hull, UK) is a silver-coated dressing reported to reduce infection and exhibit antimicrobial activity in wounds. Objective: The purpose of the present study was to compare the efficacy of acticoat□ and 1% silver sulfadiazine (1% AgSD) for treatment of partial thickness burn wounds. Material and Method: The authors reviewed 50 patients who had partial thickness burn wounds less than 25% admitted to Siriraj Burn Unit from May 2002 to September 2005. All patients were divided into 2 groups: the acticoat□ treated group (25 patients) and the 1% silver sulfadiazine treated group (25 patients). The 2 groups were compared for the etiology of burn wound, demographic data including age, sex,% Total Body Surface Area burn (TBSA%), cultured organisms, wound infection and outcome of Length Of hospital Stay (LOS) and level of pain. Results: The authors found no significant differences in age, TBSA(%) between both groups. 7 patients (28%) developed wound infection. There were no differences in wound infection and LOS between both groups (p > 0.05). All of the patients who developed wound infection responded well to targeted topical and systemic antibiotic treatment. The 1% AgSD treated group (6 of 25, 24%) obtained more split thickness skin graft to close the granulation defects compared to patients who were treated with acticoat™ (4 of 25,16%) but no statistical significance, p = 0.32). Average pain scores in the acticoat™ treated groups were significantly lower than the 1% AgSD treated group (4 □ 0.6 versus 5 □ 0.7, respectively). Conclusion: The present study confirms the efficacy of acticoat□ treatment in partial thickness burn wound. The authors conclude that acticoat□ has an advantage of limiting the frequency of replacement of the dressing and provides a less painful alternative to wound care with 1% AgSD with comparable incidence of burn wound infection. This is due to its long wear time and the ease of application and removal.